Pulsed ElectRic FiEld Versus Cryoballoon for PAF

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.

Also called NCT07100834

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 269 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07100834
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Croatia, Greece, Italy, Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07100834. Randomized; single masking; primary purpose treatment. Start 2023-09-27 (actual); primary completion 2024-05-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulsed ElectRic FiEld Versus Cryoballoon for PAF
Acronym
PERFECT-PAF
Condition
Atril Fibrillation
Condition
Cardiac Arrhythmia
Condition
Paroxysmal Atrial Fibrillation (PAF)
Intervention (Device)
Single-Shot Pulsed Field Ablation (FARAPULSE™ Pulsed Field Ablation System)
Intervention (Device)
Single-Shot Cryoballoon Devices (Arctic Front Advance PRO, Medtronic Inc., Minneapolis, MN, USA; POLARx and POLARx FIT Balloon Catheter, Marlborough, MA, USA)
Lead sponsor
Universitair Ziekenhuis Brussel (class: other)

Record details

Record id
cardio:ct-nct07100834
Content hash
eaa991c97ab28dc9854ee0d21c7a253fcda8c1e4742c582bdcebc629824cbffd